Balanced news tone
News Sentiment
PROK sentiment intelligence
ProKidney Corp. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
87/100 classification confidence.
directly relevant articles
high-authority source matches
-13.8% over one week, -9.8% over four weeks, trend inactive, and below fair value.
ProKidney Corp. (PROK) Q1 2026 Earnings: In-Line EPS, Pre-Revenue Progress Drives Modest Stock Gain - Consensus Miss Rate
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
ProKidney Corp. (PROK) Q1 2026 Earnings: In-Line EPS, Pre-Revenue Progress Drives Modest Stock Gain - Consensus Miss Rate
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 19 Jul 2026 10:31
- Source
- dars.gov.et
ProKidney Corp (PROK) Technical Analysis: Support, Resistance, Indicators & Moving Averages
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 07:00
- Source
- TradingKey
ProKidney Corp. (PROK) Declines Sharply: Key Support Level Under Scrutiny - MFI Overbought
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 14 Jul 2026 02:33
- Source
- dars.gov.et
ProKidney (NASDAQ:PROK): Can This Penny Stock Rebound?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 20:23
- Source
- Kalkine Media
ProKidney (NASDAQ: PROK) CTO awarded 750,000 stock options at $1.89 strike
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Stock Titan
ProKidney Corp. (PROK) Rallies 7.4%: Biotech Stock Approaches Key Resistance Level - Factor Crowding
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 17:40
- Source
- dars.gov.et
ProKidney Corp. (PROK) Rallies 7.4%: Biotech Stock Approaches Key Resistance Level - Sentiment Shift
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- dars.gov.et
ProKidney Corp (PROK) Dividends & Stock Splits: Historical Payouts and Event Timeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 10:21
- Source
- TradingKey
Why ProKidney (PROK) Is Building Its Bull Case Around Rilparencel’s Accelerated Approval Path
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 17 Jun 2026 07:00
- Source
- Market source
ProKidney (NASDAQ: PROK) legal chief converts paired units to Class A stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
[Form 3] PROKIDNEY CORP. Initial Statement of Beneficial Ownership
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Stock Titan
ProKidney Appoints Kenneth Locke as Chief Technical Officer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- GlobeNewswire
ProKidney Reports First Quarter 2026 Financial Results and Business Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- GlobeNewswire
ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue Estimates
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- Market source
ProKidney (PROK) Appoints Greg Madison as CCO to Lead Commercial Strategy for Rilparencel
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Market source
What Makes ProKidney Corp. (PROK) So Attractive
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Mar 2026 07:00
- Source
- Market source
ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably (NASDAQ:PROK)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Jan 2026 08:00
- Source
- Seeking Alpha